초록 ▼

A catalase-dependent enzymatic oxidation process wherein a substrate to be oxidized is contacted with catalase in the absence of hydrogen peroxide is provided. Also provided are methods for using this process in a variety of biomedical, clinical and diagnostic applications as well as industrial proc

A catalase-dependent enzymatic oxidation process wherein a substrate to be oxidized is contacted with catalase in the absence of hydrogen peroxide is provided. Also provided are methods for using this process in a variety of biomedical, clinical and diagnostic applications as well as industrial processes. A method for stimulating the enzymatic oxidation process by treatment with ultraviolet light and uses for this method are also provided.

대표청구항 ▼

What is claimed is: 1. An enzymatic oxidation process wherein a selected substrate to be oxidized is contacted with mammalian catalase in the absence of hydrogen peroxide. 2. The enzymatic oxidation process of claim 1 wherein the selected substrate is oxidized by mammalian catalase to a fluoresce

What is claimed is: 1. An enzymatic oxidation process wherein a selected substrate to be oxidized is contacted with mammalian catalase in the absence of hydrogen peroxide. 2. The enzymatic oxidation process of claim 1 wherein the selected substrate is oxidized by mammalian catalase to a fluorescent product. 3. The enzymatic oxidation process of claim 1 wherein the selected substrate is oxidized by mammalian catalase to a chemiluminescent product. 4. A screening assay for compounds that inhibit mammalian catalase comprising measuring oxidation of a selected substrate for hydrogen peroxide independent mammalian catalase activity by mammalian catalase in the presence and absence of a test compound, wherein a decrease in oxidation of the selected substrate in the presence of the test compound is indicative of the test compound inhibiting hydrogen peroxide independent mammalian catalase activity. 5. A screening assay to identity pharmacological agents activated by oxidation comprising contacting the pharmacological agent with mammalian catalase and measuring for activation of the pharmacological agent in the absence of hydrogen peroxide. 6. The screening assay of claim 5 wherein the pharmacological agent is a prodrug and activation is measured by amount of drug produced. 7. A method for accelerating oxidation of a selected substrate for hydrogen peroxide independent mammalian catalase activity by mammalian catalase comprising exposing a mixture containing the selected substrate and mammalian catalase to a low dose of ultraviolet B radiation ranging between 2.5 and 25 mJ/cm2 at a wavelength between 290 and 320 nanometers.